Sensex
81,091.63 profit arw -600.35 (-0.73%)
Nifty
24,735.05 profit arw -153.15 (-0.62%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 12-Jun-2025
Corporate News
12-Jun-2025     10:41

Zydus' Ankleshwar API unit clears USFDA inspection

Zydus Lifesciences has received the Establishment Inspection Report (EIR) report from the US FDA for the inspection conducted at its API manufacturing facility located at Ankleshwar. This facility underwent an inspection from 10th to 14th March 2025, and the inspection has been classified as No Action Indicated (NAI). The USFDA has concluded that this inspection is 'closed'.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

81,091.63 -600.35 (-0.73%)

Nifty

24,735.05 -153.15 (-0.62%)

GLOBAL INDICES

USD

85.75 0.06 (0.95%)

NASDAQ
HANG SENG

24,035.39 -331.56(-1.36%)